(Q43861785)

27 November 2017

Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin). (English)

1 reference

bilirubin metabolic disorder

27 November 2017

1 reference

5

A Kappas

1 reference

27 November 2017

4

G S Drummond

1 reference

27 November 2017

J C Martínez

1

1 reference

PubMed ID

11803428

27 November 2017

H O García

series ordinal

2

1 reference

PubMed ID

11803428

27 November 2017

L E Otheguy

series ordinal

3

1 reference

27 November 2017

1 December 2001

1 reference

27 November 2017

Journal of Perinatology

1 reference

27 November 2017

21 Suppl 1

1 reference

27 November 2017

S101-3; discussion S104-7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jp.7210655

27 November 2017

0 references

cites work

Early discharge from the newborn nursery-effect on scheduling of follow-up visits by pediatricians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

Control of heme metabolism with synthetic metalloporphyrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210655

7 January 2021

Dimensions Publication ID

Identifiers

DOI

10.1038/SJ.JP.7210655

0 references

0 references

1 reference

PubMed ID

11803428